External beam radiation therapy proves to be radical treatment for very high risk localized prostate cancer in active elderly patient





prostate cancer, very high risk, radiotherapy, complete pathological response


We present the case report of radical treatment of localized very high risk prostate cancer (рТ2сN0M0 Gleason score 5+5=10, GG5/5, initial total PSA=5 ng/ml) in active elderly patient by IMRT radiotherapy on linear accelerator Novalis Tx with definitive treatment dose 66 Gy without concomitant hormonal therapy. Efficiency of radiotherapy was demonstrated by PSA nadir <0.003 ng/ml, complete pathological response and absence of vital malignant tissue on histological study. The pathology study of the eradiated prostate gland was performed two years after radiotherapy on the specimen obtained after radical cystprostatectomy due to recurrent high-grade muscle-invasive bladder cancer. This way we could confirm that IMRP radiotherapy with dose of 66 Gy is a radical treatment of very high risk localized prostate cancer.


Mottet N., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Cumberbatch, M. G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gil¬lessen, S., Grivas, N., Grummet, J., Henry, A. M., van der Kwast, T. H., Lam T. B., Lardas, M., Liew, M., Mason, M. D., Moris, L. … Cornford, P. (2021). EAU-EANM-ESTRO-ESUR-SIOG Guide¬lines on Prostate Cancer-2020 Update. Part 1: Screening, diagnosis, and local treatment with curative intent. Eur Urol. 79(2), 243-262. https://doi.org/10.1016/j.eururo.2020.09.042

Guy, D., Glicksman, R., Buckley, R., Cheung, P., Chung, H., Flax, S., Hajek, D., Loblaw, A., Morton, G., Noakes, J., Spevack, L., Chin, J. L. K., & Rodrigues, G. (2022). Metastatic progression following multimodal therapy for unfavorable-risk prostate cancer. Can Urol Assoc J. 16(4), E220-E6. https://doi.org/10.5489/cuaj.7525

Yamashita, H., Ogita, M., Sawayanagi, S., Noza-wa, Y., & Abe, O. (2022). Quality of life after definitive linear accelerator-based stereotactic radiotherapy for prostate cancer: a longitudinal study. Radiat Oncol. 17(1), 90. https://doi.org/10.1186/s13014-022-02061-y

Nakanishi, E., Hirata, T., Tamari, K., Isohashi, F., Suzuki, O., Hayashi, K., Seo, Y., Akino, Y., Fumimoto, Y., Hatano, K., Kawashima, A., Uemura, M., Shimizu, S., Nonomura, N., & Ogawa, K., (2022). Long-term outcomes of radiation therapy for prostate cancer in elderly patients aged ≥75 years. Anticancer Res.42(7), 3529-3536. https://doi.org/10.21873/anticanres.15839

Viani, G. A., Gouveia, A. G., Moraes, F. Y., & Cury, F. L. (2022). Meta-analysis of elective pelvic nodal irradiation using moderate hypofrac¬tionation for high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 113(5), 1044-1053. https://doi.org/10.1016/j.ijrobp.2022.04.008

Costello, A. J. (2020). Considering the role of radical prostatectomy in 21st century prostate cancer care. Nat Rev Urol. 17(3), 177-188. https://doi.org/10.1038/s41585-020-0287-y

Wu, S. Y., Chang, S. C., Chen, C. I., & Huang, C. C. (2021). Oncologic outcomes of radical prostatectomy and high-dose intensity-modulated radiothe¬rapy with androgen-deprivation therapy for rela¬tively young patients with unfavorable intermediate-risk prostate adenocarcinoma. Cancers (Basel). 13(7). https://doi.org/10.3390/cancers13071517

Shih, H. J., Chang, S. C., Hsu, C. H., Lin, Y. C., Hung, C. H., & Wu, S. Y. (2021). Comparison of clinical outcomes of radical prostatectomy versus IMRT with long-term hormone therapy for rela¬tively young patients with high- to very high-risk localized prostate cancer. Cancers (Basel). 13(23). https://doi.org/10.3390/cancers13235986

Ma, K., Song, P., Qing, Y., Li, Y., Shu, M., Yang, L., & Dong, Q. (2022). The survival outcomes of very young and elderly patients with high-risk prostate cancer after radical treatments: A population-matched study. J Cancer Res Ther. 18(2), 391-398. https://doi.org/10.4103/jcrt.jcrt_1862_21

Mora, S., Qi, J., Morgan, T. M., Brede, C. M., Peabody, J., George, A., & Lane, B.R. (2022). Radical prostatectomy for patients with high-risk, very-high risk, or radiographic suspicion for metastatic prostate cancer: Perioperative and early oncologic results from the MUSIC statewide collaborative. Urol Oncol. 40(8), 380.e1-380.e9. https://doi.org/10.1016/j.urolonc.2022.05.029